Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| International Diabetes Center at Park Nicollet | OTHER |
| Sanofi | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study will record the impact of food on blood glucose levels using continuous glucose monitoring (CGM).
The investigators think the impact will improve as medication doses are adjusted. The investigators also think that the impact will differ depending on the type of medication taken.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Glargine Group | After baseline titration of metformin, this group will take glargine along with metformin. | ||
| Exenatide Group | After baseline titration of metformin, this group will take exenatide along with metformin. | ||
| Glargine and Exenatide Group | After baseline titration of metformin, this group will take glargine and exenatide along with metformin. |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| 4-hour glycemic response at 3 time points | The four-hour glycemic response includes: four-hour post-meal area under the median interstitial glucose curve, post-meal interstitial glucose peak, time to peak, time to return to pre-prandial level (to within 10% of baseline with a maximum of the 4-hour post-meal fast), difference between peak and baseline, average rate of change in interstitial glucose across the 4 hour post-meal period, and percent of the 4-hour post-meal glucose readings >180 mg/dL. | 4 hours |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Participants in Clinical Trials Study NCT01089569
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Maggie Powers, PhD | International Diabetes Center at Park Nicollet | Principal Investigator |
| Alice Shapiro, PhD | International Diabetes Center at Park Nicollet | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| International Diabetes Center | Minneapolis | Minnesota | 55416 | United States |
Not provided
| ID | Term |
|---|---|
| D003924 | Diabetes Mellitus, Type 2 |
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| D004700 | Endocrine System Diseases |